Assess Before Rx: Reducing the Overtreatment of Asymptomatic Blood Pressure Elevation in the Inpatient Setting. Issue 3 (1st March 2019)

• Record Type: Journal Article
• Authors: Pasik, Sara D; Chiu, Sophia; Yang, Jeong; Sinfield, Catherine; Zubizarreta, Nicole; Ramkeesoon, Rosemarie; Cho, Hyung J; Krouss, Mona
• Is Part Of: Journal of hospital medicine. Volume 14:Issue 3(2019)
• Page Start: 151
• Page End: 156
• Publication Date: 2019-03-01
• Subjects: Hospital care -- Periodicals; Clinical medicine -- Periodicals; 610
• DOI: 10.12788/jhm.3190
• Languages: English
• ISSNs: 1553-5592

Abstract

Abstract : BACKGROUND: Asymptomatic blood pressure elevation is common in the inpatient setting. National guidelines recommend treating with oral agents to slowly decrease blood pressure; however, many clinicians use intravenous antihypertensive medications, which can lead to unpredictable changes in blood pressure. OBJECTIVE: To decrease the number of inappropriate orders (without symptoms of hypertensive emergency or order for NPO) of intravenous antihypertensives and adverse events associated with intravenous orders. DESIGN: Quasi‐experimental study with multidisciplinary intervention. PARTICIPANTS: Inpatients with a one‐time order for an intravenous antihypertensive agent from January 2016 to February 2018. MAIN MEASURES: The main outcomes were the total numbers of orders and inappropriate orders, adverse events, and alternate etiologies per 1, 000 patient‐days. As a balancing measure, patients were monitored for adverse events when blood pressure was elevated and not treated. KEY RESULTS: There were a total of 260 one‐time orders of intravenous antihypertensives on two medical units. Inappropriate orders decreased from 8.3 to 3.3 per 1, 000 patient days ( P = .0099). Adverse events associated with intravenous antihypertensives decreased from 3.7 to 0.8 per 1, 000 patient days ( P = .0072). CONCLUSION: This initiative demonstrated a significant reduction in inappropriate use of IV antihypertensives and an associated reduction in adverse events.